首页 >
法规速递
-
Page: Frequently asked questions-2026/6/2
2026-06-02查看详情 > -
Document: Meeting report of the EMA cancer medicines forum 14 November 2025-2026/7/14
2026-07-15查看详情 > -
国家药监局药审中心关于发布《溶瘤病毒产品药学研究与评价技术指导原则（试行）》的通告（2023年第2号）-2023/02/13
2023-02-13查看详情 > -
Final Guidance: Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act--Compliance Policies-2023/8/25
2023-09-01查看详情 > -
关于公开征求《化学仿制药参比制剂目录（第九十批）》（征求意见稿）意见的通知-2025/1/2
2025-01-03查看详情 > -
国家药监局关于发布支持化妆品原料创新若干规定的公告（2025年第12号）-2025/2/6
2025-02-10查看详情 > -
Document: List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment-2025/3/13
2025-03-14查看详情 > -
Document: Call for scientific data for the use in HMPC assessment work on Valerianae radix and Passiflorae herba-2025/4/15
2025-04-16查看详情 > -
Page: Nitrosamine impurities: guidance for marketing authorisation holders-2025/5/28
2025-05-29查看详情 > -
Document: Minutes of the COMP meeting 13-15 May 2025-2025/7/1
2025-07-02查看详情 >
